NLSP logo

NLS Pharmaceutics AG (NLSP) Cash From Financing

Annual CFF

$1.63 M
-$15.76 M-90.61%

01 December 2023

NLSP Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NLSP Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-90.6%--
3 y3 years+224.5%--
5 y5 years+192.8%--

NLSP Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-92.0%+224.5%
5 y5 years-92.0%+300.9%
alltimeall time-92.0%+300.9%

NLS Pharmaceutics AG Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2023
$1.63 M(-90.6%)
-
-
Dec 2022
$17.40 M(-14.5%)
-
-
Dec 2021
$20.34 M(+3939.3%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
$503.50 K(+23.6%)
-
-
Dec 2019
$407.50 K(-27.0%)
-
-
Dec 2018
$557.90 K(-91.7%)
-
-
Dec 2017
$6.73 M
-
-

FAQ

  • What is NLS Pharmaceutics AG annual cash flow from financing activities?
  • What is the all time high annual CFF for NLS Pharmaceutics AG?
  • What is NLS Pharmaceutics AG annual CFF year-on-year change?

What is NLS Pharmaceutics AG annual cash flow from financing activities?

The current annual CFF of NLSP is $1.63 M

What is the all time high annual CFF for NLS Pharmaceutics AG?

NLS Pharmaceutics AG all-time high annual cash flow from financing activities is $20.34 M

What is NLS Pharmaceutics AG annual CFF year-on-year change?

Over the past year, NLSP annual cash flow from financing activities has changed by -$15.76 M (-90.61%)